Agilent to appeal patent office decision on CRISPR gRNA patents
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Subscribe To Our Newsletter & Stay Updated